Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients – results from real-life prospective study. Issue 2 (28th January 2020)

Record Type:: Journal Article
Title:: Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients – results from real-life prospective study. Issue 2 (28th January 2020)
Main Title:: Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients – results from real-life prospective study
Authors:: Horňák, Tomáš
Semerád, Lukáš
Žáčková, Daniela
Weinbergerová, Barbora
Šustková, Zuzana
Procházková, Jiřina
Bělohlávková, Petra
Stejskal, Lukáš
Rohoň, Peter
Faber, Edgar
Žák, Pavel
Mayer, Jiří
Ráčil, Zdeněk
Abstract:
Is Part Of:: Leukemia & lymphoma. Volume 61:Issue 2(2020)
Journal:: Leukemia & lymphoma
Issue:: Volume 61:Issue 2(2020)
Issue Display:: Volume 61, Issue 2 (2020)
Year:: 2020
Volume:: 61
Issue:: 2
Issue Sort Value:: 2020-0061-0002-0000
Page Start:: 494
Page End:: 496
Publication Date:: 2020-01-28
Subjects:: Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419
Journal URLs:: http://informahealthcare.com ↗
DOI:: 10.1080/10428194.2019.1672054 ↗
Languages:: English
ISSNs:: 1042-8194
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 17052.xml